International Congress London 2016

Saturday, 03.09.2016
Sunday, 04.09.2016
Monday, 05.09.2016
Tuesday, 06.09.2016
Wednesday, 07.09.2016

 

Sponsored symposia:

Industry Evening Mini Symposium at ERS 2016: “Challenges in the management of non-CF bronchiectasis”

Citations should be made in the following way: Authors. Title. Eur Respir J 2016; 48: Suppl. 60, abstract number.


Novel strategies on COPD and asthma management

Oral Presentation
Chairs: Omar Usmani (London, United Kingdom)
LATE-BREAKING ABSTRACT: Real life impact of long acting beta-2-agonist withdrawal in controlled step 3 asthma patients
Sunny Jabbal (Dundee, United Kingdom), Sunny Jabbal, Arvind Manoharan, William Anderson, Joseph Lipworth, Brian Lipworth
Congress or journal article abstractSlide presentationE-poster
Congress or journal article abstractSlide presentationE-poster
LATE-BREAKING ABSTRACT: The benefits of [italic]Nigella sativa[/italic] oil supplementation on asthma inflammation: A randomised, double-blind, placebo-controlled, phase II trial
Abdulrahman Koshak (London, United Kingdom), Abdulrahman Koshak, Li Wei, Emad Koshak, Siraj Wali, Omer Alamoudi, Abdulrahman Demerdash, Majdy Qutub, Peter Pushparaj, Michael Heinrich
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
LATE-BREAKING ABSTRACT: Association of incident pneumonia and exacerbations with extrafine beclometasone dipropionate/formoterol (BDP/FF) in severe COPD patients: A post-hoc analysis of FORWARD study
Massimo Corradi (Parma, Italy), Massimo Corradi, Monica Spinola, Alessandro Guasconi, Géraldine Cohuet, Isabella Montagna, Andrea Bizzi, Stefano Petruzzelli
Congress or journal article abstract
Congress or journal article abstract
LATE-BREAKING ABSTRACT: Benralizumab provides significant improvements for patients with severe, uncontrolled asthma: SIROCCO Phase III results
Eugene R. Bleecker (Winston-Salem, United States of America), Eugene Bleecker, J. Mark FitzGerald, Pascal Chanez, Alberto Papi, Steve Weinstein, Peter Barker, Stephanie Sproule, Geoffrey Gilmartin, Magnus Aurivillius, Viktoria Werkström, Mitchell Goldman
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
LATE-BREAKING ABSTRACT: Indacaterol/glycopyrronium (IND/GLY) reduces the risk of exacerbations versus salmeterol/fluticasone (SFC) in moderate-to-very severe COPD patients irrespective of prior ICS/LABA/LAMA therapy: The FLAME study
Wisia Wedzicha (London, United Kingdom), Jadwiga Wedzicha, Karen Mezzi, Tim Ayers, Chau Thach, Robert Fogel, Francesco Patalano, Donald Banerji
Congress or journal article abstract
Congress or journal article abstract
LATE-BREAKING ABSTRACT: Pulmonary deposition of a novel LAMA/LABA Co-Suspension[sup][trade][/sup] technology glycopyrronium/formoterol (GFF) MDI in healthy subjects (PT003020)
Sarvajna Dwivedi (Redwood City, United States of America), Glyn Taylor, Simon Warren, Chad Orevillo, Andrea Maes, Ubaldo J. Martin, Sarvajna Dwivedi, Colin Reisner
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
LATE-BREAKING ABSTRACT: IgE immunadsorption in allergic bronchopulmonary aspergillosis: A pilot study
Siva Mahendran (Watford, United Kingdom), Siva Mahendran, Rosemary Ebling, Mohammad Ibrahim, Tariq Sethi
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
LATE-BREAKING ABSTRACT: Corticosteroid responsiveness in COPD
Nausherwan Burki (Farmington, United States of America), Nausherwan Burki, Marsden Granger, Debapriya Datta
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation